WILLIAM COOKE: Open Payments
NPI 1699749770 · AUSTIN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$17,788 in 43 payments from 11 companies in 2025. Trend: 2023 $683 · 2024 $5,237 · 2025 $17,788
Speaker / faculty: $14,700Travel & lodging: $1,995Food & beverage: $1,093
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $17,286 |
| ViiV Healthcare Company | 4 | $281 |
| EMD Serono, Inc. | 3 | $51 |
| Vanda Pharmaceuticals Inc. | 2 | $46 |
| Alkermes, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Medtronic, Inc. | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: MAVYRET, CABENUVA, DOVATO, UBRELVY, FANAPT, VRAYLAR, ARISTADA, CAPLYTA.
Industry payments across IN — which companies pay providers there.
